H.C. Wainwright lowered the firm’s price target on Pacira to $68 from $71 and keeps a Buy rating on the shares. The analyst believes expectations heading into the company’s Q2 results are “very low,” below sell-side consensus estimates, based on weak third-party data sales estimates through May. The stock is near a bottom and already reflects an expected Q2 miss, while indications support a back-half of 2023 improvement, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue